Drexel Morgan & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,896
| Closed | -$372K | – | 80 |
|
|
2021
Q1 | $372K | Sell |
5,896
-10
| -0.2% | -$622 | 0.09% | 77 |
|
|
2020
Q4 | $366K | Hold |
5,906
| – | – | 0.1% | 75 |
|
|
2020
Q3 | $356K | Sell |
5,906
-2,632
| -31% | -$158K | 0.13% | 74 |
|
|
2020
Q2 | $502K | Hold |
8,538
| – | – | 0.19% | 58 |
|
|
2020
Q1 | $476K | Sell |
8,538
-770
| -8% | -$47.1K | 0.18% | 56 |
|
|
2019
Q4 | $597K | Buy |
9,308
+2
| +0% | +$115 | 0.45% | 49 |
|
|
2019
Q3 | $472K | Buy |
9,306
+8
| +0.1% | +$376 | 0.36% | 55 |
|
|
2019
Q2 | $422K | Hold |
9,298
| – | – | 0.33% | 63 |
|
|
2019
Q1 | $444K | Hold |
9,298
| – | – | 0.39% | 58 |
|
|
2018
Q4 | $483K | Hold |
9,298
| – | – | 0.48% | 52 |
|
|
2018
Q3 | $577K | Hold |
9,298
| – | – | 0.51% | 49 |
|
|
2018
Q2 | $515K | Hold |
9,298
| – | – | 0.52% | 51 |
|
|
2018
Q1 | $588K | Hold |
9,298
| – | – | 0.61% | 46 |
|
|
2017
Q4 | $570K | Hold |
9,298
| – | – | 0.55% | 50 |
|
|
2017
Q3 | $593K | Hold |
9,298
| – | – | 0.61% | 48 |
|
|
2017
Q2 | $518K | Hold |
9,298
| – | – | 0.53% | 49 |
|
|
2017
Q1 | $506K | Hold |
9,298
| – | – | 0.56% | 50 |
|
|
2016
Q4 | $543K | Hold |
9,298
| – | – | 0.65% | 47 |
|
|
2016
Q3 | $501K | Hold |
9,298
| – | – | 0.56% | 51 |
|
|
2016
Q2 | $684K | Hold |
9,298
| – | – | 0.78% | 46 |
|
|
2016
Q1 | $594K | Hold |
9,298
| – | – | 0.7% | 50 |
|
|
2015
Q4 | $640K | Hold |
9,298
| – | – | 0.71% | 47 |
|
|
2015
Q3 | $550K | Hold |
9,298
| – | – | 0.71% | 43 |
|
|
2015
Q2 | $619K | Hold |
9,298
| – | – | 0.73% | 43 |
|
|
2015
Q1 | $600K | Sell |
9,298
-140
| -1% | -$8.76K | 0.64% | 49 |
|
|
2014
Q4 | $557K | Hold |
9,438
| – | – | 0.63% | 47 |
|
|
2014
Q3 | $483K | Sell |
9,438
-1,210
| -11% | -$60.4K | 0.59% | 54 |
|
|
2014
Q2 | $517K | Sell |
10,648
-184
| -2% | -$9.07K | 0.62% | 48 |
|
|
2014
Q1 | $563K | Buy |
10,832
+140
| +1% | +$7.45K | 0.71% | 42 |
|
|
2013
Q4 | $568K | Hold |
10,692
| – | – | 0.77% | 42 |
|
|
2013
Q3 | $495K | Hold |
10,692
| – | – | 0.68% | 44 |
|
|
2013
Q2 | $478K | Buy |
+10,692
| New | +$464K | 0.79% | 35 |
|
Other funds holding BMY
Drexel Morgan & Co's BMY Position: Q2 2021 in Review
Drexel Morgan & Co sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 5,896 shares — an estimated $372K sold.
Drexel Morgan & Co first reported a position in BMY in Q2 2013 and held it in 32 quarters. The position peaked at $684K in Q2 2016. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Drexel Morgan & Co reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
- Drexel Morgan & Co sold 5,896 Bristol-Myers Squibb shares in Q2 2021, an estimated $372K.
- Drexel Morgan & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 32 quarters.
- Drexel Morgan & Co's Bristol-Myers Squibb position peaked at $684K in Q2 2016.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Drexel Morgan & Co's 13F filing for Q2 2021, filed 12 Aug 2021.